Nintedanib, Pirfenidone cancer drugs give hope to patients battling idiopathic pulmonary fibrosis According to new clinical trial results, two drugs were able to make breathing easier among IPF or idiopathic pulmonary fibrosis sufferers. Nintedanib and Pirfenidone might be available in the market in 2015. by Anne Francis